Human chromosome 17 in essential hypertension

Area of Science:

• Genetics
• Cardiovascular Disease
• Nephrology

Background:

• Hypertension impacts 30% of Western adults, a key risk factor for kidney disease, stroke, and heart disease.
• The complex etiology of hypertension involves genetic and environmental factors, with precise causes still under investigation.
• Genetic research methods, successful for Mendelian traits, are now applied to complex diseases like hypertension.

Purpose of the Study:

• To review evidence implicating chromosome 17 genes in human essential hypertension.
• To summarize findings from rodent models and human studies, including pseudohypoaldosteronism type II.
• To outline various genetic approaches used in hypertension research.

Main Methods:

• Review of rodent models for hypertension.
• Analysis of human hypertension studies, including monogenic traits like pseudohypoaldosteronism type II.
• Examination of candidate gene studies, genome screens, and linkage analyses.

Main Results:

• Evidence suggests the involvement of one or more genes on chromosome 17 in human essential hypertension.
• Studies in rodents and humans, including specific genetic disorders, have been conducted.
• No definitive gene on human chromosome 17 has been identified to date that causes essential hypertension.

Conclusions:

• While chromosome 17 is implicated, no specific gene has been confirmed to cause human essential hypertension.
• Ongoing fine-mapping and candidate gene studies in both rodents and humans are crucial.
• Further research is anticipated to identify genetic factors contributing to hypertension.